Advertisement

Topics

Clontech Laboratories Incorporated Company Profile

01:32 EST 21st November 2017 | BioPortfolio

Clontech Laboratories provides kits, reagents, and services that help researchers explore questions about gene discovery, regulation, and function. As the newest member of the Takara Bio Group, Clontech joins a company that holds a leadership position in the global market and is committed to improving the human condition through biotechnology. Clontech’s mission is to develop high-quality innovative tools and services to accelerate discovery.

Innovation

In order to maintain our position as an industry leader, we foster an environment of collaboration and discovery for our research scientists and with the research community at large. Our scientists are leaders in their fields and publish regularly in leading peer-reviewed journals such as Biotechniques, Science, and PNAS. Clontech holds over 30 patents and offers novel tools for studying gene expression analysis, subcellular localization, apoptosis, and signal transduction. In addition, our scientists have authored guides and publications that are industry standards in technologies ranging from PCR to gene expression profiling to yeast two-hybrid systems.

We actively seek research and business partnerships with industry innovators and leaders. Our research and development efforts have resulted in award winning technologies and the introduction of novel tools to the market. Clontech introduced the first commercially available antibody microarray, a unique tool that allows users to study hundreds of cellular proteins in one experiment. We have also received R&D 100 awards for our fluorescent proteins, apoptosis detection systems, cDNA arrays, tet-regulated gene expression systems, and retroviral expression systems.

Location

1290 Terra Bella Ave.
Mountain View
CA
94043
United States of America

Contact

Phone: 650-919-7300
Fax: 650-424-1064
Email: orders@clontech.com


News Articles [288 Associated News Articles listed on BioPortfolio]

Vical Incorporated Announces Pricing of $25 Million Underwritten Public Offering of Common Stock

SAN DIEGO, Nov. 08, 2017 (GLOBE NEWSWIRE) -- Vical Incorporated (Nasdaq:VICL) today announced the pricing of its underwritten public offering of 14,285,714 shares of common stock or common stock ...

Contrasting IDEXX Laboratories

IDEXX Laboratories and Heska Corporation are both medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, di...

Enterome to move its research laboratories

Enterome, a pioneer of innovative therapies for microbiome-related diseases announced that the Company is moving its research laboratories to Genopole, a leading biocluster dedicated to biotechnology ...

Dr. Reddy's Laboratories Ltd (RDY) Set to Announce Earnings on Tuesday

Dr. Reddy's Laboratories Ltd will be releasing its earnings data after the market closes on Tuesday, October 31st. Shares of Dr. Reddy's Laboratories Ltd traded down 0.28% during midday tradin...

Impax Laboratories (IPXL) vs. Lannett Co (LCI) Financial Survey

Impax Laboratories and Lannett Co are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, risk...

$0.14 EPS Expected for Impax Laboratories, Inc. (IPXL) This Quarter

Analysts expect Impax Laboratories, Inc. to report earnings per share of $0.14 for the current fiscal quarter, according to Zacks . Four analysts have provided estimates for Impax Laboratories' ea...

#jobs #lifescience Vector Laboratories: Marketing Manager

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Vector Laboratories: Marketing Manager . Competitive Salary and Benefits: Vec...

Abbott Laboratories Q3 Earnings Rise 32%

NORTH CHICAGO (dpa-AFX) - Abbott Laboratories (ABT) released a profit for its third quarter that climbed from last year.The company said its bottom line advanced to $1.16 billion, or $0.66 per sha...

PubMed Articles [174 Associated PubMed Articles listed on BioPortfolio]

Project management: importance for diagnostic laboratories.

The constraints applied on diagnostic laboratories to improve both quality and productivity together with personal shortages incite laboratory managers to constantly optimize the laboratory workflows,...

Repeatability and variability of total T4 measurements at three German veterinary laboratories.

To evaluate the reproducibility of serum testing for total thyroxine (T4) in three German laboratories.

Survey of laboratory practices for diagnosis of fungal infection in seven Asian countries: An Asia Fungal Working Group (AFWG) initiative.

An online survey of mycology laboratories in seven Asian countries was conducted to assess the status, competence, and services available. Country representatives from the Asia Fungal Working Group (A...

Cancer incidence in female laboratory employees: extended follow-up of a Swedish cohort study.

Work in chemical laboratories is associated with exposure to chemicals, of which some are known or suspected carcinogens. A cohort study of laboratory workers in Stockholm followed until 1992 showed a...

Understanding variations in secondary findings reporting practices across U.S. genome sequencing laboratories.

Increasingly used for clinical purposes, genome and exome sequencing can generate clinically relevant information that is not directly related to the reason for testing (incidental or secondary findin...

Clinical Trials [237 Associated Clinical Trials listed on BioPortfolio]

A Comparative Clinical Trial to Evaluate the Safety and Clinical Equivalence of Clotrimazole Troche/Lozenges USP, 10mg (Unique Pharmaceutical Laboratories, India) With Clotrimazole Troche 10mg (Roxane Laboratories Inc., USA) in Subjects With Oropharyngeal

The objectives of this study are to compare the efficacy and safety of Clotrimazole troche/ lozenges USP, 10 mg (Unique Pharmaceutical Laboratories, India) vs. Clotrimazole Troche/ Lozenge...

Bioequivalence Study of Meloxicam Tablets 15 mg of Dr.Reddy's Laboratories Limited Under Fed Condition

The objective of this study is to determine the relative bioavailability of one 15 mg Meloxicam tablet (Dr. Reddy. Laboratories Ltd.,Generics) versus one 15 mg Mobic (meloxicam) Tablet (Bo...

Bioequivalence Study of Dr.Reddy's Laboratories Limited Finasteride Tablets 1 mg Under Fed Condition

The objective of this study was to compare the single-dose relative bioavailability of Dr. Reddy's Laboratories, Ltd. and Merck & Co. (Propecia®) 1 mg finasteride tablets under fed condi...

Bioequivalence Study of Meloxicam Tablets 15 mg of Dr.Reddy's Laboratories Limited Under Fasting Condition

The objective of this study is to determine the relative bioavailability of one 15 mg Meloxicam tablet (Dr. Reddy. Laboratories Ltd.,Generics) versus one 15 mg Mobic (meloxicam) Tablet (Bo...

Bioequivalence Study of Dr. Reddy's Laboratories Limited, Finasteride Tablets 1 mg Under Fasting Condition

The objective of this study was to compare the single-dose relative bioavailability of Dr. Reddy's Laboratories, Ltd. and Merck & Co. (Propecia®) 1 mg finasteride tablets under fasting c...

Companies [974 Associated Companies listed on BioPortfolio]

Clontech Laboratories, Inc

Clontech Laboratories, Inc. develops, produces, and markets innovative biological products to the life science market worldwide. Clontech is a wholly owned subsidiary of Takara Bio, Inc.

BD Clontech

Clontech Laboratories, Inc. develops, produces, and markets innovative biological products to the life science market worldwide. Clontech is a wholly owned subsidiary of Takara Bio, Inc.

Clontech Laboratories, Inc.

Clontech Laboratories, Inc., a wholly-owned subsidiary of Takara Bio Inc., develops, manufactures, and distributes a wide range of life science research reagents under the Clontech and Takara brands. ...

Clontech Laboratories Incorporated

Clontech Laboratories provides kits, reagents, and services that help researchers explore questions about gene discovery, regulation, and function. As the newest member of the Takara Bio Group, Clonte...

Clontech

Provider of GFP, GAL4, cell cycle, phosphoamino acid, phosphokeratin, and other antibodies, as well as many other innovative molecular and cell biology-related products

More Information about "Clontech Laboratories Incorporated" on BioPortfolio

We have published hundreds of Clontech Laboratories Incorporated news stories on BioPortfolio along with dozens of Clontech Laboratories Incorporated Clinical Trials and PubMed Articles about Clontech Laboratories Incorporated for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Clontech Laboratories Incorporated Companies in our database. You can also find out about relevant Clontech Laboratories Incorporated Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topics

Bioinformatics
Bioinformatics is the application of computer software and hardware to the management of biological data to create useful information. Computers are used to gather, store, analyze and integrate biological and genetic information which can then be applied...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...


Corporate Database Quicklinks



Searches Linking to this Company Record